Hematopoietic failure after hemorrhagic shock is mediated partially through mesenteric lymph

D J Anjaria1, P Rameshwar, E A Deitch

  • 1Department of Surgery, UMDNJ-New Jersey Medical School, Newark, NJ, USA.

Critical Care Medicine
|September 8, 2001
PubMed
Abstract

Insights

Hemorrhagic shock impairs bone marrow hematopoiesis. Mesenteric lymph duct ligation prevents this bone marrow failure, indicating the gut mediates shock-induced bone marrow suppression.

Area of Science:

  • Hematology
  • Gastroenterology
  • Surgical Research

Background:

  • Hemorrhagic shock can lead to bone marrow failure.
  • The gut's role in this process is not fully understood.

Purpose of the Study:

  • To investigate if toxic mesenteric lymph mediates hemorrhagic shock-induced bone marrow failure.
  • To determine if ligating mesenteric lymphatics can prevent this bone marrow failure.

Main Methods:

  • A prospective, controlled study was conducted on male Sprague-Dawley rats.
  • Rats underwent hemorrhagic shock with or without mesenteric lymph duct ligation.
  • Bone marrow hematopoietic progenitor cell growth was assessed post-resuscitation.

Main Results:

  • Mesenteric lymph duct ligation prevented the decrease in bone marrow cellularity and progenitor cell growth observed in shocked rats.
  • Plasma from shocked rats without ligation inhibited hematopoietic progenitor cell growth, while plasma from ligated rats did not.

Conclusions:

  • Hemorrhagic shock suppresses bone marrow hematopoiesis.
  • This suppression is mediated by the gut via mesenteric lymph.
  • Mesenteric lymph duct ligation abrogates shock-induced bone marrow failure.